What stocks does SBI HEALTHCARE OPPORTUNITIES FUND hold?

SBI HEALTHCARE OPPORTUNITIES FUND holds a portfolio of Indian equity stocks disclosed monthly by SBI Mutual Fund to AMFI. The complete current holdings with weights and month-over-month changes are available on this page. Data is sourced from official AMFI portfolio disclosures.

Which AMC manages SBI HEALTHCARE OPPORTUNITIES FUND?

SBI HEALTHCARE OPPORTUNITIES FUND is managed by SBI Mutual Fund, a SEBI-registered Asset Management Company in India.

What category is SBI HEALTHCARE OPPORTUNITIES FUND?

SBI HEALTHCARE OPPORTUNITIES FUND is classified as a Equity mutual fund under SEBI's mutual fund categorisation framework.

How often is SBI HEALTHCARE OPPORTUNITIES FUND portfolio data updated?

Portfolio holdings for SBI HEALTHCARE OPPORTUNITIES FUND are updated monthly. SEBI mandates all AMCs to disclose their complete portfolio within 10 days of each month end. RightAdvise sources this data directly from official AMFI portfolio disclosures.

← SBI Mutual Fund

SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH

Equity Data as of Aug 2026 Comparing Jul 2026 → Aug 2026

Share: WhatsApp X

⌕

Stocks Held

Aug 2026

Equity Holdings

₹5,609.84 Cr

Equity only, excl. debt & cash

AAUM

₹4,318.95 Cr

Apr-Jun 2026 · Direct + Regular

Top 5 Weight

35.0%

Moderate

Top 10 Weight

55.4%

Moderate

Changes

0 new · 1 exits

Top Sector

Pharmaceuticals & Biotechnology

64.9% of portfolio

Launch Date

01 Jan 1993

10+ year track record

AAUM (Average Assets Under Management) of ₹4,318.95 Cr for Apr-Jun 2026 is the combined figure across Direct and Regular plans — sourced from AMFI India's quarterly disclosure. Equity Holdings above shows only the stock portion from the latest portfolio filing.

📋 What Happened This Month SBI HEALTHCARE OPPORTUNITIES FUND exited 1 stock from its portfolio this month. Lupin Limited was the biggest exit (Pharmaceuticals & Biotechnology), which was held at 1.79%. Among existing holdings, Divi's Laboratories Limited saw the biggest increase — now at 8.17% of the portfolio. Abbott India Limited was trimmed the most, now at 0.35%. Sun Pharmaceutical Industries Limited remains the top holding with Pharmaceuticals & Biotechnology the dominant sector at 64.9%. ↓ Scroll down for full holdings, sector allocation and month-on-month changes in detail.

How Has the NAV Performed?

1 year history · SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH

+0.59%

+11.84%

+27.87%

+21.59%

Latest NAV

₹605.91

11 Sep 2026

52W High

₹610.69

-1% from High

52W Low

₹442.50

+37% from Low

Calendar Year Returns

Jan 1 to Dec 31 each year. Simple point-to-point — not CAGR.

2025

-2.5%

2024

+43.8%

2023

+39.7%

2022

-5.0%

2021

+21.5%

2020

+67.7%

2019

+0.5%

2018

-8.8%

2017

+3.3%

Rolling Returns

Performance across every possible investment start date.

1Y Rolling Avg

16.8%

+ve in 66% windows

86.5% / -18.1%

3Y Rolling Avg

18.0% p.a.

+ve in 85% windows

32.2% / -9.6%

5Y Rolling Avg

18.8% p.a.

+ve in 100% windows

34.0% / 6.9%

Crisis Period Behaviour

"Pre-inception" = fund didn't exist during that period.

2024–25 Tariff

-13.5%

Rec: Jul 2025 (7 mo)

COVID-19 Crash

-22.7%

Rec: Apr 2020 (1 mo)

2022 Rate Hike

-16.0%

Rec: May 2023 (1yr 4mo)

2018 IL&FS

-14.4%

Rec: Apr 2020 (2yr 1mo)

Risk Ratios

3 years daily NAV · Risk-free rate 6.5% p.a. · CAGR, Sharpe Ratio & Standard Deviation — Mutual Fund Guide →

Sharpe Ratio (3Y)

1.40

Return per unit of risk. >1 is good.

Sortino Ratio (3Y)

2.03

Penalises downside volatility only.

Std Deviation (3Y)

12.8%

Lower = more consistent returns.

NAV Chart ₹605.91 11 Sep 2026

Simple Moving Avg: Click to draw · click again to remove

SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH

Chart shows indexed performance (base = 100). Actual NAV: ₹605.91

Sector Shift Industry allocation month-over-month

Jun 2026 → Jul 2026

Sector	Prev	Curr ▼	Delta
Pharmaceuticals & Biotechnology	64.2%	66.8%	▲ +2.7%
Healthcare Services	26.1%	27.2%	▲ +1.1%
Chemicals & Petrochemicals	2.7%	2.3%	▼ -0.4%
Healthcare Equipment & Supplies	2.2%	2.0%	▼ -0.1%

Jul 2026 → Aug 2026

Sector	Prev	Curr ▼	Delta
Pharmaceuticals & Biotechnology	66.8%	64.9%	▼ -2.0%
Healthcare Services	27.2%	27.6%	▲ +0.5%
Chemicals & Petrochemicals	2.3%	2.3%	● +0.1%
Healthcare Equipment & Supplies	2.0%	1.9%	● -0.1%

🔴

Biggest Exit

Lupin Limited

1.79% was held · Pharmaceuticals & Biotechnology

↑

Biggest Add

Divi's Laboratories Limited

+0.71% · now 8.17%

↓

Biggest Trim

Abbott India Limited

-0.68% · now 0.35%

👋 Other funds also exited

Lupin Limited 41 funds

What Changed in the Portfolio This Month?

Comparing Jul 2026 → Aug 2026

Jul 2026 → Aug 2026

🔴 1 Exit ↑ 13 Increased ↓ 18 Decreased

#	Stock	Sector	Last Weight (Jul 2026)
1	Lupin Limited ₹96.60 Cr	Pharmaceuticals & Biotechnology	1.79%

#	Stock	Sector	Jul 2026	Aug 2026	Change
1	Divi's Laboratories Limited ₹473.35 Cr	Pharmaceuticals & Biotechnology	7.46%	8.17%	+0.71%
2	Sudeep Pharma Limited ₹164.52 Cr	Pharmaceuticals & Biotechnology	2.22%	2.84%	+0.62%
3	Healthcare Global Enterprises Limited ₹73.33 Cr	Healthcare Services	0.73%	1.27%	+0.54%
4	Concord Biotech Limited ₹138.83 Cr	Pharmaceuticals & Biotechnology	1.89%	2.40%	+0.51%
5	Dr. Lal Path Labs Limited ₹85.12 Cr	Healthcare Services	1.06%	1.47%	+0.41%
6	Syngene International Limited ₹72.14 Cr	Healthcare Services	0.96%	1.24%	+0.28%
7	Global Health Limited ₹110.98 Cr	Healthcare Services	1.67%	1.91%	+0.24%
8	Gland Pharma Limited ₹173.15 Cr	Pharmaceuticals & Biotechnology	2.78%	2.99%	+0.21%
9	Fortis Healthcare Limited ₹163.24 Cr	Healthcare Services	2.63%	2.82%	+0.19%
10	Anthem Biosciences Limited ₹167.89 Cr	Pharmaceuticals & Biotechnology	2.82%	2.90%	+0.08%
11	Sai Life Sciences Limited ₹145.97 Cr	Pharmaceuticals & Biotechnology	2.44%	2.52%	+0.08%
12	Aether Industries Limited ₹135.25 Cr	Chemicals & Petrochemicals	2.28%	2.33%	+0.05%
13	Aurobindo Pharma Limited ₹226.33 Cr	Pharmaceuticals & Biotechnology	3.86%	3.90%	+0.04%

#	Stock	Sector	Jul 2026	Aug 2026	Change
1	Abbott India Limited ₹20.07 Cr	Pharmaceuticals & Biotechnology	1.03%	0.35%	-0.68%
2	Cipla Limited ₹270.57 Cr	Pharmaceuticals & Biotechnology	5.07%	4.67%	-0.40%
3	Sun Pharmaceutical Industries Limited ₹714.53 Cr	Pharmaceuticals & Biotechnology	12.72%	12.33%	-0.39%
4	Jupiter Life Line Hospitals Limited ₹147.80 Cr	Healthcare Services	2.88%	2.55%	-0.33%
5	Biocon Limited ₹154.50 Cr	Pharmaceuticals & Biotechnology	2.96%	2.67%	-0.29%
6	Max Healthcare Institute Limited ₹250.10 Cr	Healthcare Services	4.58%	4.31%	-0.27%
7	Acutaas Chemicals Ltd ₹284.45 Cr	Pharmaceuticals & Biotechnology	5.17%	4.91%	-0.26%
8	Krishna Institute Of Medical Sciences Limited ₹100.57 Cr	Healthcare Services	1.98%	1.73%	-0.25%
9	Mankind Pharma Limited ₹96.77 Cr	Pharmaceuticals & Biotechnology	1.83%	1.67%	-0.16%
10	Aster DM Healthcare Limited ₹204.12 Cr	Healthcare Services	3.65%	3.52%	-0.13%
11	Rainbow Childrens Medicare Limited ₹42.44 Cr	Healthcare Services	0.85%	0.73%	-0.12%
12	Laurus Labs Limited ₹229.80 Cr	Pharmaceuticals & Biotechnology	4.04%	3.96%	-0.08%
13	Poly Medicure Limited ₹112.61 Cr	Healthcare Equipment & Supplies	2.02%	1.94%	-0.08%
14	Apollo Hospitals Enterprise Limited ₹284.75 Cr	Healthcare Services	4.98%	4.91%	-0.07%
15	Ajanta Pharma Limited ₹107.83 Cr	Pharmaceuticals & Biotechnology	1.93%	1.86%	-0.07%
16	Gufic Biosciences Ltd. ₹16.65 Cr	Pharmaceuticals & Biotechnology	0.36%	0.29%	-0.07%
17	Torrent Pharmaceuticals Limited ₹273.56 Cr	Pharmaceuticals & Biotechnology	4.74%	4.72%	-0.02%
18	Nephrocare Health Services Ltd ₹68.30 Cr	Healthcare Services	1.20%	1.18%	-0.02%

What Stocks Does This Fund Hold?

32 stocks — Aug 2026

#	Stock	Sector	Weight & Value
1	Sun Pharmaceutical Industries Limited ₹714.53 Cr	Pharmaceuticals & Biotechnology	12.33%
2	Divi's Laboratories Limited ₹473.35 Cr	Pharmaceuticals & Biotechnology	8.17%
3	Apollo Hospitals Enterprise Limited ₹284.75 Cr	Healthcare Services	4.91%
4	Acutaas Chemicals Ltd ₹284.45 Cr	Pharmaceuticals & Biotechnology	4.91%
5	Torrent Pharmaceuticals Limited ₹273.56 Cr	Pharmaceuticals & Biotechnology	4.72%
6	Cipla Limited ₹270.57 Cr	Pharmaceuticals & Biotechnology	4.67%
7	Max Healthcare Institute Limited ₹250.10 Cr	Healthcare Services	4.31%
8	Laurus Labs Limited ₹229.80 Cr	Pharmaceuticals & Biotechnology	3.96%
9	Aurobindo Pharma Limited ₹226.33 Cr	Pharmaceuticals & Biotechnology	3.90%
10	Aster DM Healthcare Limited ₹204.12 Cr	Healthcare Services	3.52%
11	Gland Pharma Limited ₹173.15 Cr	Pharmaceuticals & Biotechnology	2.99%
12	Anthem Biosciences Limited ₹167.89 Cr	Pharmaceuticals & Biotechnology	2.90%
13	Sudeep Pharma Limited ₹164.52 Cr	Pharmaceuticals & Biotechnology	2.84%
14	Fortis Healthcare Limited ₹163.24 Cr	Healthcare Services	2.82%
15	Biocon Limited ₹154.50 Cr	Pharmaceuticals & Biotechnology	2.67%
16	Jupiter Life Line Hospitals Limited ₹147.80 Cr	Healthcare Services	2.55%
17	Sai Life Sciences Limited ₹145.97 Cr	Pharmaceuticals & Biotechnology	2.52%
18	Concord Biotech Limited ₹138.83 Cr	Pharmaceuticals & Biotechnology	2.40%
19	Aether Industries Limited ₹135.25 Cr	Chemicals & Petrochemicals	2.33%
20	Poly Medicure Limited ₹112.61 Cr	Healthcare Equipment & Supplies	1.94%
21	Global Health Limited ₹110.98 Cr	Healthcare Services	1.91%
22	Ajanta Pharma Limited ₹107.83 Cr	Pharmaceuticals & Biotechnology	1.86%
23	Krishna Institute Of Medical Sciences Limited ₹100.57 Cr	Healthcare Services	1.73%
24	Cohance Lifesciences Limited ₹100.31 Cr	Pharmaceuticals & Biotechnology	1.73%
25	Mankind Pharma Limited ₹96.77 Cr	Pharmaceuticals & Biotechnology	1.67%
26	Dr. Lal Path Labs Limited ₹85.12 Cr	Healthcare Services	1.47%
27	Healthcare Global Enterprises Limited ₹73.33 Cr	Healthcare Services	1.27%
28	Syngene International Limited ₹72.14 Cr	Healthcare Services	1.24%
29	Nephrocare Health Services Ltd ₹68.30 Cr	Healthcare Services	1.18%
30	Rainbow Childrens Medicare Limited ₹42.44 Cr	Healthcare Services	0.73%
31	Abbott India Limited ₹20.07 Cr	Pharmaceuticals & Biotechnology	0.35%
32	Gufic Biosciences Ltd. ₹16.65 Cr	Pharmaceuticals & Biotechnology	0.29%